Public health experts and government leaders agree that easy access to testing for COVID-19 will be critical to managing the virus’ spread and re-opening the world’s economies. However, a shortage of specialized nasopharyngeal swabs used to collect samples for diagnosis is one of several bottlenecks in the way of widespread testing. Now a clinical trial conducted by a multi-disciplinary team coordinated by Ramy Arnaout, MD, DPhil (Clinical Microbiology Laboratories, BIDMC) has identified four novel prototypes of 3D-printed swabs that can be used for COVID-19 testing.
A multi-disciplinary team including Ramy Arnaout, MD, DPhil (Clinical Microbiology Laboratories, BIDMC) is collaborating to develop 3D printable swabs for COVID-19 testing.
Kevin Tabb, MD (President & CEO, BILH) will appear at a WBUR virtual town hall on Tuesday, April 21st at 6 pm to discuss upcoming challenges for health care in Massachusetts after the sure in COVID-19 cases ends.
AT&T pledges to cover every US healthcare worker..
About 1,000 spring flowers, some of which were meant to line the route of the 2020 Boston Marathon ...
Jimmy Kimmel honored Taylor Chase-Meyers, RN (ICU, BIDMC) on his show Tuesday night as a thank-you for the work she’s been doing on the frontlines of the COVID-19 pandemic.
Lindon Beckford (Patient Transport, BIDMC) sang a song of appreciation for his colleagues on the frontlines fighting COVID-19.
Sharon Wright, MD (Infection Control, BIDMC) answers common questions regarding COVID-19.
The federal government and Johnson & Johnson are investing more than $1 billion in a potential vaccine to prevent COVID-19 developed by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) and his team.